CAT and acute lymphoblastic leukemia: More general markers of malignancy include Catalase (CAT), which was detected in the CSF of B- and T-ALL patients with cytospin CNS2-status [35], supporting adaption to hypoxic glycolysis in CNS-ALL blasts [40].